These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 23076294

  • 1. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.
    Ferraz-de-Souza B, Martin RM, Correa PH.
    J Bone Miner Metab; 2013 May; 31(3):360-5. PubMed ID: 23076294
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 3. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 4. Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
    Polyzos SA, Anastasilakis AD, Litsas I, Efstathiadou Z, Kita M, Arsos G, Moralidis E, Papatheodorou A, Terpos E.
    J Bone Miner Metab; 2010 Nov; 28(6):706-12. PubMed ID: 20533067
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of Paget's disease of bone: a mini-review.
    Ferraz-de-Souza B, Correa PH.
    Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):577-82. PubMed ID: 24343625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 10. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar 01; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 11. Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.
    Noriega Aldave AP, Jaiswal S.
    J Med Case Rep; 2014 Oct 23; 8():353. PubMed ID: 25342294
    [Abstract] [Full Text] [Related]

  • 12. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Oct 23; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

  • 13. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.
    Cronin O, Forsyth L, Goodman K, Lewis SC, Keerie C, Walker A, Porteous M, Cetnarskyj R, Ranganath LR, Selby PL, Hampson G, Chandra R, Ho S, Tobias JH, Young-Min S, McKenna MJ, Crowley RK, Fraser WD, Gennari L, Nuti R, Brandi ML, Del Pino-Montes J, Devogelaer JP, Durnez A, Isaia G, Di Stefano M, Guañabens N, Blanch J, Seibel MJ, Walsh JP, Kotowicz MA, Nicholson GC, Duncan EL, Major G, Horne A, Gilchrist NL, Boers M, Murray GD, Charnock K, Wilkinson D, Russell RGG, Ralston SH.
    BMJ Open; 2019 Sep 04; 9(9):e030689. PubMed ID: 31488492
    [Abstract] [Full Text] [Related]

  • 14. Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementation.
    Tucci JR, Bone HG, Su G, Tan M, Ozturk ZE, Aftring P.
    Ther Adv Endocrinol Metab; 2015 Aug 04; 6(4):155-62. PubMed ID: 26301065
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Aug 04; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 16. Vertex extradural hematoma in association with Paget's disease of the skull.
    Ramesh VG, Deiveegan K, Soundappan V.
    Neurol India; 2005 Mar 04; 53(1):115-6. PubMed ID: 15805671
    [Abstract] [Full Text] [Related]

  • 17. Paget's disease of bone and osteonecrosis.
    Seehra J, Sloan P, Oliver RJ.
    Dent Update; 2009 Apr 04; 36(3):166-8, 171-2. PubMed ID: 19480105
    [Abstract] [Full Text] [Related]

  • 18. Effect of bisphosphonate treatment in patients with Paget's disease of the skull.
    Donáth J, Krasznai M, Fornet B, Gergely P, Poór G.
    Rheumatology (Oxford); 2004 Jan 04; 43(1):89-94. PubMed ID: 12923287
    [Abstract] [Full Text] [Related]

  • 19. Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease.
    Merlotti D, Rendina D, Muscariello R, Picchioni T, Alessandri M, De Filippo G, Materozzi M, Bianciardi S, Franci MB, Lucani B, Cenci S, Strazzullo P, Nuti R, Gennari L.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 31634910
    [Abstract] [Full Text] [Related]

  • 20. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May 01; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.